As we've covered before, these fears are based on studies with rodents
CJC-1295 and Tesamorelin are both GHRH-side compounds, but they are different molecules with different profiles, so a Tesamorelin + Ipamorelin blend is not interchangeable with a CJC-1295 + Ipamorelin blend
Theyre coming to us on these medications and our practice is typically to discontinue it
Liraglutide, though, has been in shortage since April 2023, so the compounders are free to keep making it
U., Caruso, U., Cravotto, E., D'Iddio, S., Corsi, M., Pola, P., Savi, L., and Grilli, M
Theyre evidence-based treatments indicated for obesity (BMI 30) or BMI 27 with a weight-related condition within comprehensive carenot casual thinness